Blood MUC-18/MCAM expression in patients with melanoma: a suitable marker of poor outcome-Reference-Cited by-同舟云学术

Blood MUC-18/MCAM expression in patients with melanoma: a suitable marker of poor outcome

Published:2013-07 Issue:1 Volume:169 Page:221-222
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Rapanotti M.C.¹,Ricozzi I.²,Campione E.²,Orlandi A.³,Bianchi L.²

Affiliation:

1. Department of Laboratory Medicine; Policlinico di Tor Vergata; Tor Vergata University of Rome; Viale Oxford 81 00133 Rome Italy

2. Department of Dermatology and ; Policlinico di Tor Vergata; Tor Vergata University of Rome; Viale Oxford 81 00133 Rome Italy

3. Department of Anatomic Pathology; Policlinico di Tor Vergata; Tor Vergata University of Rome; Viale Oxford 81 00133 Rome Italy

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12295/fullpdf

Reference5 articles.

1. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay;Hoon;J Clin Oncol,1995

2. Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma;Reynolds;Clin Cancer Res,2003

3. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression;Reid;Br J Dermatol,2013

4. The challenge of developing useful blood-based biomarkers in melanoma;Sullivan;Br J Dermatol,2013

5. Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients;Rapanotti;Br J Dermatol,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance;International Journal of Molecular Sciences;2023-07-22

2. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy;International Journal of Molecular Sciences;2021-11-17

3. Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study;Cancer Cell International;2021-06-08

4. Stem–Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients;Frontiers in Molecular Biosciences;2020-05-29

5. Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors;International Journal of Cancer;2020-02-22